Table 4.
Adjusted analyses assessing the association of preoperative opioid use with 6-month adverse events, the proportion of “Much Better” on the global perceived improvement scale, Oxford and EQ-VAS scores
| Adjusted Analysis | Opioid user (Odds Ratio (95CI)) | P value | AUC |
| Total adverse events | 0.85 (0.61, 1.19) | 0.35 | 0.63 |
| Acute significant adverse events | 1.05 (0.55, 1.96) | 0.87 | 0.66 |
| Total significant adverse events | 0.94 (0.57, 1.50) | 0.79 | 0.64 |
| 6-month “Much Better” | 0.93 (0.61, 1.43) | 0.73 | 0.64 |
| Adjusted Analysis | Opioid user (MD (95CI)) | P value | Adjusted R 2 |
| 6-month Oxford Score | -0.34 (-1.63, 0.95) | 0.60 | 0.08 |
| 6-month EQ-VAS | -2.26 (-5.16, 0.61) | 0.12 | 0.09 |
95 CI 95% Confidence intervals. AUC Area under the curve, MD Mean difference